|
![]() |
|||
|
||||
OverviewThe book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment. Full Product DetailsAuthor: Veysel KayserPublisher: Mdpi AG Imprint: Mdpi AG Dimensions: Width: 17.00cm , Height: 2.40cm , Length: 24.40cm Weight: 0.839kg ISBN: 9783036526874ISBN 10: 3036526870 Pages: 298 Publication Date: 25 January 2022 Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |